Effect of sevoflurane
lymphocytes
neutrophil-to-lymphocyte ratio
oncoanaesthesia
propofol
sevoflurane
Journal
BJA open
ISSN: 2772-6096
Titre abrégé: BJA Open
Pays: England
ID NLM: 9918419157906676
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
27
02
2022
accepted:
07
03
2022
medline:
13
4
2022
pubmed:
13
4
2022
entrez:
17
8
2023
Statut:
epublish
Résumé
Sevoflurane and propofol are commonly used drugs in general anaesthesia. However, their effects on perioperative immune function are incompletely understood. We hypothesised that sevoflurane and propofol differentially affect immune function in healthy individuals. Therefore, we investigated the effect of sevoflurane and propofol on neutrophil-to-lymphocyte ratio before, during, and after general anaesthesia. In this randomised crossover study, 19 healthy individuals underwent 2 h of general anaesthesia with either propofol or sevoflurane. After 4 weeks, anaesthesia was repeated using the other drug. Blood samples were obtained before, during, 1 h after, and 1 day after anaesthesia. The primary outcome was whole-blood neutrophil-to-lymphocyte ratio, and secondary outcomes were specific white blood cell differential counts. A linear mixed-effects model was used to estimate effect sizes. The neutrophil-to-lymphocyte ratio was higher in the propofol compared with the sevoflurane group during anaesthesia, 2.8 (confidence interval [CI]: 2.3-3.3) In healthy individuals undergoing general anaesthesia without surgery, the neutrophil-to-lymphocyte ratio was affected by the type of hypnotic used. Transient lymphopaenia was observed in all participants during propofol anaesthesia.
Sections du résumé
Background
UNASSIGNED
Sevoflurane and propofol are commonly used drugs in general anaesthesia. However, their effects on perioperative immune function are incompletely understood. We hypothesised that sevoflurane and propofol differentially affect immune function in healthy individuals. Therefore, we investigated the effect of sevoflurane and propofol on neutrophil-to-lymphocyte ratio before, during, and after general anaesthesia.
Methods
UNASSIGNED
In this randomised crossover study, 19 healthy individuals underwent 2 h of general anaesthesia with either propofol or sevoflurane. After 4 weeks, anaesthesia was repeated using the other drug. Blood samples were obtained before, during, 1 h after, and 1 day after anaesthesia. The primary outcome was whole-blood neutrophil-to-lymphocyte ratio, and secondary outcomes were specific white blood cell differential counts. A linear mixed-effects model was used to estimate effect sizes.
Results
UNASSIGNED
The neutrophil-to-lymphocyte ratio was higher in the propofol compared with the sevoflurane group during anaesthesia, 2.8 (confidence interval [CI]: 2.3-3.3)
Conclusions
UNASSIGNED
In healthy individuals undergoing general anaesthesia without surgery, the neutrophil-to-lymphocyte ratio was affected by the type of hypnotic used. Transient lymphopaenia was observed in all participants during propofol anaesthesia.
Identifiants
pubmed: 37588265
doi: 10.1016/j.bjao.2022.100005
pii: S2772-6096(22)00004-1
pmc: PMC10430840
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100005Informations de copyright
© 2022 The Author(s).
Références
Acta Anaesthesiol Taiwan. 2011 Sep;49(3):83-7
pubmed: 21982167
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13757-13766
pubmed: 32467161
Anaesthesia. 2010 May;65(5):478-82
pubmed: 20337621
Br J Anaesth. 2021 May;126(5):921-930
pubmed: 33386126
Nature. 2011 Jan 20;469(7330):428-31
pubmed: 21248852
Anesthesiology. 2016 Aug;125(2):399-411
pubmed: 27286478
Future Oncol. 2018 May;14(12):1187-1196
pubmed: 29302993
J Pharmacol Pharmacother. 2010 Jul;1(2):100-7
pubmed: 21350618
Curr Opin Anaesthesiol. 2021 Jun 1;34(3):317-325
pubmed: 33935180
World J Surg Oncol. 2015 Jun 04;13:194
pubmed: 26040932
Anaesth Intensive Care. 2018 Sep;46(5):480-487
pubmed: 30189822
Can J Anaesth. 2019 May;66(5):546-561
pubmed: 30834506
Am J Surg. 2009 Feb;197(2):238-45
pubmed: 18639228
Cochrane Database Syst Rev. 2017 Apr 04;4:CD011387
pubmed: 28374886
Nat Rev Clin Oncol. 2018 Apr;15(4):205-218
pubmed: 29283170
Mol Interv. 2001 Dec;1(5):258-68
pubmed: 14993365
Front Immunol. 2018 Mar 19;9:547
pubmed: 29616038
Trends Pharmacol Sci. 2005 Oct;26(10):503-10
pubmed: 16126282
Oncology. 2015;88(6):337-44
pubmed: 25721153
Ann Surg Oncol. 2016 Jan;23(1):335-42
pubmed: 26152275
Nat Rev Cancer. 2005 Apr;5(4):263-74
pubmed: 15776005
Anesthesiology. 2020 Oct 1;133(4):764-773
pubmed: 32930730
Best Pract Res Clin Anaesthesiol. 2021 Dec;35(4):491-505
pubmed: 34801212
Br J Anaesth. 2021 Feb;126(2):343-347
pubmed: 33246582
J Immunol. 2017 Apr 1;198(7):2534-2541
pubmed: 28320914
BMC Anesthesiol. 2019 Dec 5;19(1):222
pubmed: 31805854
Cancers (Basel). 2019 Apr 28;11(5):
pubmed: 31035321
Onco Targets Ther. 2016 Oct 21;9:6529-6537
pubmed: 27799800
Anaesthesia. 2018 May;73(5):603-611
pubmed: 29457215
Acta Anaesthesiol Scand. 2021 Feb;65(2):151-161
pubmed: 33108695
Blood. 2006 Nov 15;108(10):3253-61
pubmed: 16868248
Trials. 2020 Sep 22;21(1):805
pubmed: 32962743